ardsley school of music LLC

po box 522
harrison, new york 10528

NYS Entity Status
INACTIVE - Dissolution (Aug 06, 2013)

NYS Filing Date
JUNE 13, 2013

NYS DOS ID#
4417386

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - ARDSLEY SCHOOL OF MUSIC LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Harrison’s concerto bridges the traditions of East and West
    By Joshua Kosman - Tuesday Oct 31, 2017

    Many composers have combined Asian and European musical strains over the years, but few have done it with the tenderness and quiet elegance of the late Lou Harrison. He put his hand to a wide range of Eastern traditions, from Korean court music to Indonesian gamelan, and imbued all of it with his signature melody and grace. Harrison’s 1997 Concerto for Pipa and Orchestra is the centerpiece of the upcoming concert by the China National Centre for the Performing Arts Orchestra, and it features Wu Man — a virtuoso of the lute-like instrument who also maintains a stylistic connection to both the U.S. and her native China — as soloist.

    Source: SFGATE.com: Entertainment News
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another
    By Frank Vinluan - Monday Nov 20, 2017

    Acorda Therapeutics said Monday that it will stop work on an experimental treatment for Parkinson’s disease, spelling the end for a drug the Ardsley, NY, company added to its pipeline last year in a $363 million deal. The announcement follows the recent emergence of safety problems for the Acorda (NASDAQ: ACOR) drug, tozadenant. Acorda said […]

    Source: Xconomy New York
  • 20th Street Block Party ready to rock
    By Aidin Vaziri - Tuesday Aug 15, 2017

    The electronic pop band Neon Indian, experimental act Kilo Kish and dreamy lo-fi group Hoops are among the acts slated to perform at this year’s 20th Street Block Party, Noise Pop’s annual free daytime music festival, set for Saturday, Aug. 19.In the heart of San Francisco’s Mission District, the outdoor concert takes place on 19th and 20th streets around and between Bryant and Harrison streets, with two stages, local vendors and food trucks lining the sidewalk.[...] as with last year, the festival will benefit the nonprofit Mission Language and Vocational School, which provides occupational training to mostly Latino unemployed and working-class immigrants and their families.

    Source: SFGATE.com: Entertainment News
  • Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study
    By Ben Fidler - Wednesday Nov 15, 2017

    Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear. Ardsley, NY-based Acorda (NASDAQ: ACOR) said Wednesday morning that it has seen troubling safety problems in a Phase 3 trial of its experimental Parkinson’s disease drug tozadenant. Acorda reported cases […]

    Source: Xconomy New York
  • Partnership Aims to Mend Funding for School Music Programs
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Tuesday Nov 7, 2017

    The Philadelphia school system has found a creative solution to address the problem of broken musical instruments....

    Source: Philanthropy News Digest (PND)